Harbor Capital Advisors Inc. Sells 52,489 Shares of Quanterix Co. (NASDAQ:QTRX)

Harbor Capital Advisors Inc. lessened its position in shares of Quanterix Co. (NASDAQ:QTRX) by 27.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 139,955 shares of the company’s stock after selling 52,489 shares during the period. Harbor Capital Advisors Inc. owned approximately 0.36% of Quanterix worth $1,488,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Portolan Capital Management LLC increased its holdings in shares of Quanterix by 31.4% in the third quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock worth $32,668,000 after purchasing an additional 602,656 shares during the period. Envestnet Asset Management Inc. increased its stake in Quanterix by 2,261.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 209,731 shares of the company’s stock worth $2,771,000 after acquiring an additional 200,851 shares during the last quarter. Easterly Investment Partners LLC raised its holdings in shares of Quanterix by 26.5% in the 3rd quarter. Easterly Investment Partners LLC now owns 876,133 shares of the company’s stock valued at $11,355,000 after acquiring an additional 183,387 shares in the last quarter. abrdn plc boosted its position in shares of Quanterix by 163.6% during the 3rd quarter. abrdn plc now owns 166,398 shares of the company’s stock valued at $2,157,000 after acquiring an additional 103,281 shares during the last quarter. Finally, Pier Capital LLC grew its holdings in shares of Quanterix by 23.5% during the third quarter. Pier Capital LLC now owns 511,798 shares of the company’s stock worth $6,633,000 after purchasing an additional 97,256 shares in the last quarter. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, TD Cowen lifted their target price on shares of Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research report on Wednesday, November 13th.

Quanterix Trading Down 19.7 %

QTRX opened at $9.42 on Monday. The stock has a market capitalization of $362.90 million, a P/E ratio of -8.97 and a beta of 1.33. Quanterix Co. has a 12-month low of $9.16 and a 12-month high of $29.70. The stock has a 50-day moving average price of $11.91 and a 200-day moving average price of $12.66.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.